CIK 0001453593
- Non-accelerated filer
- Smaller reporting company
Xtant Medical Holdings, Inc.
Sign in to watch- Ticker
- XTNT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205313323
- Phone
- +1 406-388-0480
- Business address
- 664 CRUISER LANE, BELGRADE, MT, 59714
- Former names
- Bacterin International Holdings, Inc., K KITZ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-18 | Swanson Kent L Director | Other acquisition | +1,000 | $2.80 | $3K | 84,828 |
| 2015-12-14 | Swanson Kent L Director | Other acquisition | +552 | $3.19 | $2K | 83,828 |
| 2015-12-04 | Swanson Kent L Director | Other acquisition | +148 | $2.81 | $416 | 83,276 |
| 2015-12-03 | Swanson Kent L Director | Purchase | +300 | $2.81 | $843 | 81,128 |
| 2015-12-03 | Swanson Kent L Director | Purchase | +1,000 | $2.82 | $3K | 82,128 |
| 2015-12-03 | Swanson Kent L Director | Purchase | +1,000 | $2.83 | $3K | 83,128 |
| 2015-12-01 | Swanson Kent L Director | Purchase | +1,000 | $2.85 | $3K | 80,828 |
| 2015-11-20 | Kirschman David Louis EVP & Chief Scientific Officer | Purchase | +1,000 | $2.94 | $3K | 1,700,063 |
| 2015-11-20 | Kirschman David Louis EVP & Chief Scientific Officer | Purchase | +1,000 | $3.04 | $3K | 1,701,063 |
| 2015-11-20 | Swanson Kent L Director | Purchase | +4,976 | $3.00 | $15K | 79,828 |
| 2015-11-19 | Swanson Kent L Director | Purchase | +24 | $2.90 | $70 | 74,852 |
| 2015-11-19 | Kirschman David Louis EVP & Chief Scientific Officer | Purchase | +1,000 | $2.94 | $3K | 1,699,063 |
| 2015-11-18 | Kirschman David Louis EVP & Chief Scientific Officer | Purchase | +1,000 | $2.86 | $3K | 1,698,063 |
| 2015-11-16 | Goldberger Daniel S Chief Executive Officer | Purchase | +3,000 | $2.80 | $8K | 15,510 |
| 2015-10-12 | Kirschman David Louis EVP & Chief Scientific Officer | Grant or award · Restricted Stock Unit | +40,000 | 40,000 | ||
| 2015-09-04 | DEEDRICK JOHN ARTHUR Director | Purchase | +6,793 | $3.68 | $25K | 16,621 |
| 2015-09-04 | LOPACH MICHAEL A Director | Purchase | +10,869 | $3.68 | $40K | 14,258 |
| 2015-09-04 | Swanson Kent L Director | Purchase | +30,000 | $3.68 | $110K | 74,828 |
| 2015-09-04 | WICKWIRE JON M. Director | Purchase | +10,869 | $3.68 | $40K | 31,247 |
| 2015-09-04 | Goldberger Daniel S Chief Executive Officer | Purchase | +81,522 | $3.68 | $300K | 81,522 |
Page 14 of 19 · 371 trades